Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹2,623 Cr₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,623 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹2,623 Cr
Mar2025₹2,177 Cr
Mar2024₹1,852 Cr
Mar2023₹1,491 Cr
Mar2022₹1,376 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2026 ₹2,623 Cr
20.46
Mar2025 ₹2,177 Cr
17.56
Mar2024 ₹1,852 Cr
24.23
Mar2023 ₹1,491 Cr
8.33
Mar2022 ₹1,376 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,738.8 Cr -4.4% -5% 74.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.4%

-5%

74.9%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses